AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiyano-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Yanolite Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimiyano-M1 Tablet PR

Diabex Duo tablets are an antidiabetic medication, a dual-action formulation for adult type 2 diabetes management. This medication helps regulate blood glucose levels. Diabex Duo should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them; regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any pre-existing heart conditions before commencing treatment; it may not be appropriate. Consult your physician prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, will be necessary.

Primary Ingredients of Glimiyano-M1 Tablet PR

No text was provided to rewrite.

Uses of Glimiyano-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimiyano-M1 Tablet PR:

Follow your physician's instructions or refer to the product label for proper administration. Take Glimiyano-M1 Tablet PR with meals.

Common Side effects of Glimiyano-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiyano-M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Glimiyano-M1 Tablet PR with a meal.

How Glimiyano-M1 Tablet PR works:

Glimiyano-M1 PR tablets contain a dual-action antidiabetic formula combining glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimiyano-M1 Tablet PR is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimiyano-M1 Tablet PR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimiyano-M1 Tablet PR. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimiyano-M1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimiyano-M1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is typically prescribed for those with mild to moderate liver disease; it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimiyano-M1 Tablet PR :

Should you forget a Glimiyano-M1 Tablet PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimiyano-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glimiyano-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimiyano-M1 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimiyano-M1 Tablet PR and seek immediate medical attention.
Glimiyano-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 DM.
Glimiyano-M1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimiyano-M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended at least annually, according to some research.
Glimiyano-M1 Tablet PR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medication concurrently. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimiyano-M1 Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimiyano-M1 Tablet PR
138
MRP 160
13% off